ArticleCancers2024

Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived Xenografts.

Faizal Z Asumda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.